ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Lion TCR Receives FDA Fast Track Designation for its HBV-specific TCR T Cell Therapy for Hepatocellular Carcinoma
December 23, 2021Lion TCR Pte Ltd today announced that it has received Fast Track Designation from United States Food and Drug Administration (U.S. FDA) for LioCyx-M004, autologous T-cells transfected with mRNA encoding Hepatitis B surface antigen... -
Lion TCR Announces FDA IND Clearance for its LioCyx-M004 for Hepatocellular Carcinoma
September 28, 2021Lion TCR Pte Ltd, a clinical-stage biotech company specialized in T Cell Receptor (TCR) T cell therapy today announced that it has received clearance from U.S. Food...
Pharma Sources Insight January 2025
